pharmacogenomics
Castle Biosciences Q4 Revenues up 31 Percent
The company saw a boost in testing volume in the fourth quarter, but not across all its assays, while full-year revenues grew 51 percent.
New York State DOH Approves Solvd Lab for Clinical PGx Testing
The company markets an assay intended to predict patients' risk of developing opioid use disorder, helping physicians tailor their use of these drugs.
UBS Initiates Coverage of Myriad Genetics With Neutral Rating
Analysts noted that while continued double-digit growth appears unsustainable in the near term, risks related to UnitedHealthcare's decision on pharmacogenetic testing appear limited.
VA Offering No-Cost PGx Testing Through End of 2025
The program will be rolled out within Veterans Integrated Service Network 4 facilities, which served more than 300,000 patients last year.
The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the Kiddose PGx test.
Nov 5, 2024
Castle Biosciences Q3 Revenues up 39 Percent
Jul 29, 2024
Oct 17, 2022
Sep 26, 2022